Rafferty Asset Management, LLC Theravance Biopharma, Inc. Transaction History

Rafferty Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$8.41 - $10.34 $106,865 - $131,390	-12,707 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$8.33 - $12.96 $105,849 - $164,682	12,707 New	12,707 $121,000
Q4 2021 Feb 10, 2022	SELL	$7.42 - $11.05 $93,855 - $139,771	-12,649 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$6.77 - $14.41 $85,633 - $182,272	12,649 New	12,649 $94,000

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.